Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Experiences in fosfomycin susceptibility testing and resistance mechanism determination in Escherichia coli from urinary tract infections in the UK.

Cottell JL, Webber MA.

J Med Microbiol. 2019 Feb;68(2):161-168. doi: 10.1099/jmm.0.000901. Epub 2018 Dec 13.

PMID:
30543320
2.

CTX-M-15 is Established in Most Multidrug-Resistant Uropathogenic Enterobacteriaceae and Pseudomonaceae from Hospitals in Nigeria.

Ogbolu DO, Alli OAT, Webber MA, Oluremi AS, Oloyede OM.

Eur J Microbiol Immunol (Bp). 2018 Mar 7;8(1):20-24. doi: 10.1556/1886.2017.00012. eCollection 2018 Apr.

3.

Clinically Relevant Plasmid-Host Interactions Indicate that Transcriptional and Not Genomic Modifications Ameliorate Fitness Costs of Klebsiella pneumoniae Carbapenemase-Carrying Plasmids.

Buckner MMC, Saw HTH, Osagie RN, McNally A, Ricci V, Wand ME, Woodford N, Ivens A, Webber MA, Piddock LJV.

MBio. 2018 Apr 24;9(2). pii: e02303-17. doi: 10.1128/mBio.02303-17.

4.

Corrigendum to "A schema-focused approach to group psychotherapy for outpatients with borderline personality disorder: A randomized controlled trial" [(J. Behav. Ther. Exp. Psychiatr.) 40 (2) (June 2009) 317-328].

Farrell JM, Shaw IA, Webber MA.

J Behav Ther Exp Psychiatry. 2018 Sep;60:111. doi: 10.1016/j.jbtep.2018.04.001. Epub 2018 Apr 19. No abstract available.

PMID:
29680679
5.

Catheter sepsis and antisepsis: matters of life, death, obscurity and resistance.

Clarke P, Webber MA.

Arch Dis Child Fetal Neonatal Ed. 2018 Mar;103(2):F94-F96. doi: 10.1136/archdischild-2017-313150. Epub 2018 Jan 25. No abstract available.

PMID:
29371239
6.

Quinolone-resistant gyrase mutants demonstrate decreased susceptibility to triclosan.

Webber MA, Buckner MMC, Redgrave LS, Ifill G, Mitchenall LA, Webb C, Iddles R, Maxwell A, Piddock LJV.

J Antimicrob Chemother. 2017 Oct 1;72(10):2755-2763. doi: 10.1093/jac/dkx201.

PMID:
29091182
7.

Use of an engineered honey to eradicate preformed biofilms of important wound pathogens: an in vitro study.

Halstead FD, Webber MA, Oppenheim BA.

J Wound Care. 2017 Aug 2;26(8):442-450. doi: 10.12968/jowc.2017.26.8.442.

PMID:
28795889
8.

Novel approaches to the treatment of bacterial biofilm infections.

Hughes G, Webber MA.

Br J Pharmacol. 2017 Jul;174(14):2237-2246. doi: 10.1111/bph.13706. Epub 2017 Feb 2. Review.

9.

Erratum for Richmond et al., The Acinetobacter baumannii Two-Component System AdeRS Regulates Genes Required for Multidrug Efflux, Biofilm Formation, and Virulence in a Strain-Specific Manner.

Richmond GE, Evans LP, Anderson MJ, Wand ME, Bonney LC, Ivens A, Chua KL, Webber MA, Sutton JM, Peterson ML, Piddock LJ.

MBio. 2016 Jun 21;7(3). pii: e00852-16. doi: 10.1128/mBio.00852-16. No abstract available.

10.

Response to Letter to Editor: 'Limitations of In Vitro Antimicrobial Dressings Study'.

Webber MA.

Burns. 2016 Aug;42(5):1148. doi: 10.1016/j.burns.2016.02.015. Epub 2016 Jun 6. No abstract available.

PMID:
27283734
11.

Antibacterial Activity of Blue Light against Nosocomial Wound Pathogens Growing Planktonically and as Mature Biofilms.

Halstead FD, Thwaite JE, Burt R, Laws TR, Raguse M, Moeller R, Webber MA, Oppenheim BA.

Appl Environ Microbiol. 2016 Jun 13;82(13):4006-4016. doi: 10.1128/AEM.00756-16. Print 2016 Jul 1.

12.

Adding functionality with additive manufacturing: Fabrication of titanium-based antibiotic eluting implants.

Cox SC, Jamshidi P, Eisenstein NM, Webber MA, Hassanin H, Attallah MM, Shepherd DET, Addison O, Grover LM.

Mater Sci Eng C Mater Biol Appl. 2016 Jul 1;64:407-415. doi: 10.1016/j.msec.2016.04.006. Epub 2016 Apr 5.

PMID:
27127071
13.

The Acinetobacter baumannii Two-Component System AdeRS Regulates Genes Required for Multidrug Efflux, Biofilm Formation, and Virulence in a Strain-Specific Manner.

Richmond GE, Evans LP, Anderson MJ, Wand ME, Bonney LC, Ivens A, Chua KL, Webber MA, Sutton JM, Peterson ML, Piddock LJ.

MBio. 2016 Apr 19;7(2):e00430-16. doi: 10.1128/mBio.00430-16. Erratum in: MBio. 2016;7(3). pii: e00852-16. doi: 10.1128/mBio.00852-16.

14.

Inactivation or inhibition of AcrAB-TolC increases resistance of carbapenemase-producing Enterobacteriaceae to carbapenems.

Saw HT, Webber MA, Mushtaq S, Woodford N, Piddock LJ.

J Antimicrob Chemother. 2016 Jun;71(6):1510-9. doi: 10.1093/jac/dkw028. Epub 2016 Mar 5.

PMID:
26945714
15.

In vitro activity of an engineered honey, medical-grade honeys, and antimicrobial wound dressings against biofilm-producing clinical bacterial isolates.

Halstead FD, Webber MA, Rauf M, Burt R, Dryden M, Oppenheim BA.

J Wound Care. 2016 Feb;25(2):93-4, 96-102. doi: 10.12968/jowc.2016.25.2.93.

PMID:
26878302
16.

The Antibacterial Activity of Acetic Acid against Biofilm-Producing Pathogens of Relevance to Burns Patients.

Halstead FD, Rauf M, Moiemen NS, Bamford A, Wearn CM, Fraise AP, Lund PA, Oppenheim BA, Webber MA.

PLoS One. 2015 Sep 9;10(9):e0136190. doi: 10.1371/journal.pone.0136190. eCollection 2015.

17.

Antimicrobial dressings: Comparison of the ability of a panel of dressings to prevent biofilm formation by key burn wound pathogens.

Halstead FD, Rauf M, Bamford A, Wearn CM, Bishop JRB, Burt R, Fraise AP, Moiemen NS, Oppenheim BA, Webber MA.

Burns. 2015 Dec;41(8):1683-1694. doi: 10.1016/j.burns.2015.06.005. Epub 2015 Jul 16.

PMID:
26188884
18.

Parallel evolutionary pathways to antibiotic resistance selected by biocide exposure.

Webber MA, Whitehead RN, Mount M, Loman NJ, Pallen MJ, Piddock LJ.

J Antimicrob Chemother. 2015 Aug;70(8):2241-8. doi: 10.1093/jac/dkv109. Epub 2015 May 7.

19.

Molecular mechanisms of antibiotic resistance.

Blair JM, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJ.

Nat Rev Microbiol. 2015 Jan;13(1):42-51. doi: 10.1038/nrmicro3380. Epub 2014 Dec 1. Review.

PMID:
25435309
20.

Functional genomics to identify the factors contributing to successful persistence and global spread of an antibiotic resistance plasmid.

Cottell JL, Saw HT, Webber MA, Piddock LJ.

BMC Microbiol. 2014 Jun 24;14:168. doi: 10.1186/1471-2180-14-168.

21.

Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success.

Redgrave LS, Sutton SB, Webber MA, Piddock LJ.

Trends Microbiol. 2014 Aug;22(8):438-45. doi: 10.1016/j.tim.2014.04.007. Epub 2014 May 16. Review.

PMID:
24842194
22.

High-level and novel mechanisms of carbapenem resistance in Gram-negative bacteria from tertiary hospitals in Nigeria.

Ogbolu DO, Webber MA.

Int J Antimicrob Agents. 2014 May;43(5):412-7. doi: 10.1016/j.ijantimicag.2014.01.014. Epub 2014 Feb 12.

PMID:
24613608
23.

Multiple transmissible genes encoding fluoroquinolone and third-generation cephalosporin resistance co-located in non-typhoidal Salmonella isolated from food-producing animals in China.

Jiang HX, Song L, Liu J, Zhang XH, Ren YN, Zhang WH, Zhang JY, Liu YH, Webber MA, Ogbolu DO, Zeng ZL, Piddock LJ.

Int J Antimicrob Agents. 2014 Mar;43(3):242-7. doi: 10.1016/j.ijantimicag.2013.12.005. Epub 2013 Dec 17.

PMID:
24581597
24.

Epidemiology of Burkholderia multivorans strains obtained from non-cystic fibrosis patients isolated in large hospitals across the Czech Republic.

Hanulik V, Webber MA, Holy O, Roterva M, Kolar M.

J Hosp Infect. 2014 Jan;86(1):74-5. doi: 10.1016/j.jhin.2013.10.001. Epub 2013 Nov 9. No abstract available.

PMID:
24309418
25.

Inhibition of multidrug efflux as a strategy to prevent biofilm formation.

Baugh S, Phillips CR, Ekanayaka AS, Piddock LJ, Webber MA.

J Antimicrob Chemother. 2014 Mar;69(3):673-81. doi: 10.1093/jac/dkt420. Epub 2013 Oct 31.

PMID:
24176982
26.
27.

Clinically relevant mutant DNA gyrase alters supercoiling, changes the transcriptome, and confers multidrug resistance.

Webber MA, Ricci V, Whitehead R, Patel M, Fookes M, Ivens A, Piddock LJ.

MBio. 2013 Jul 23;4(4). pii: e00273-13. doi: 10.1128/mBio.00273-13.

28.

An outbreak of Burkholderia multivorans beyond cystic fibrosis patients.

Hanulik V, Webber MA, Chroma M, Uvizl R, Holy O, Whitehead RN, Baugh S, Matouskova I, Kolar M.

J Hosp Infect. 2013 Jul;84(3):248-51. doi: 10.1016/j.jhin.2013.04.001. Epub 2013 May 22.

PMID:
23706672
29.

Dissemination of IncF plasmids carrying beta-lactamase genes in Gram-negative bacteria from Nigerian hospitals.

Ogbolu DO, Daini OA, Ogunledun A, Terry Alli OA, Webber MA.

J Infect Dev Ctries. 2013 May 13;7(5):382-90. doi: 10.3855/jidc.2613.

30.

Laboratory adapted Escherichia coli K-12 becomes a pathogen of Caenorhabditis elegans upon restoration of O antigen biosynthesis.

Browning DF, Wells TJ, França FL, Morris FC, Sevastsyanovich YR, Bryant JA, Johnson MD, Lund PA, Cunningham AF, Hobman JL, May RC, Webber MA, Henderson IR.

Mol Microbiol. 2013 Mar;87(5):939-50. doi: 10.1111/mmi.12144. Epub 2013 Jan 28.

31.

Loss of or inhibition of all multidrug resistance efflux pumps of Salmonella enterica serovar Typhimurium results in impaired ability to form a biofilm.

Baugh S, Ekanayaka AS, Piddock LJ, Webber MA.

J Antimicrob Chemother. 2012 Oct;67(10):2409-17. doi: 10.1093/jac/dks228. Epub 2012 Jun 25.

PMID:
22733653
32.

Persistence of transferable extended-spectrum-β-lactamase resistance in the absence of antibiotic pressure.

Cottell JL, Webber MA, Piddock LJ.

Antimicrob Agents Chemother. 2012 Sep;56(9):4703-6. doi: 10.1128/AAC.00848-12. Epub 2012 Jun 18.

33.

[Detection of Burkholderia cepacia complex strains in the University Hospital Olomouc].

Hanulík V, Chromá M, Webber MA, Uvízl R, Whitehead RN, Baugh S, Htoutou Sedláková M, Kolář M.

Klin Mikrobiol Infekc Lek. 2012 Feb;18(1):4-8. Czech.

PMID:
22484971
34.

SadA, a trimeric autotransporter from Salmonella enterica serovar Typhimurium, can promote biofilm formation and provides limited protection against infection.

Raghunathan D, Wells TJ, Morris FC, Shaw RK, Bobat S, Peters SE, Paterson GK, Jensen KT, Leyton DL, Blair JM, Browning DF, Pravin J, Flores-Langarica A, Hitchcock JR, Moraes CT, Piazza RM, Maskell DJ, Webber MA, May RC, MacLennan CA, Piddock LJ, Cunningham AF, Henderson IR.

Infect Immun. 2011 Nov;79(11):4342-52. doi: 10.1128/IAI.05592-11. Epub 2011 Aug 22.

35.

Exposure of Salmonella enterica serovar Typhimurium to high level biocide challenge can select multidrug resistant mutants in a single step.

Whitehead RN, Overton TW, Kemp CL, Webber MA.

PLoS One. 2011;6(7):e22833. doi: 10.1371/journal.pone.0022833. Epub 2011 Jul 29.

36.

Neural field model of binocular rivalry waves.

Bressloff PC, Webber MA.

J Comput Neurosci. 2012 Apr;32(2):233-52. doi: 10.1007/s10827-011-0351-y. Epub 2011 Jul 12.

PMID:
21748526
37.

Use of granulated sugar therapy in the management of sloughy or necrotic wounds: a pilot study.

Murandu M, Webber MA, Simms MH, Dealey C.

J Wound Care. 2011 May;20(5):206, 208, 210 passim.

PMID:
21647066
38.

Complete sequence and molecular epidemiology of IncK epidemic plasmid encoding blaCTX-M-14.

Cottell JL, Webber MA, Coldham NG, Taylor DL, Cerdeño-Tárraga AM, Hauser H, Thomson NR, Woodward MJ, Piddock LJ.

Emerg Infect Dis. 2011 Apr;17(4):645-52. doi: 10.3201/eid1704.101009. Erratum in: Emerg Infect Dis. 2011 Jul;17(7):1341.

39.

Resistance and tolerance to tropodithietic acid, an antimicrobial in aquaculture, is hard to select.

Porsby CH, Webber MA, Nielsen KF, Piddock LJ, Gram L.

Antimicrob Agents Chemother. 2011 Apr;55(4):1332-7. doi: 10.1128/AAC.01222-10. Epub 2011 Jan 24.

40.

High levels of multidrug resistance in clinical isolates of Gram-negative pathogens from Nigeria.

Ogbolu DO, Daini OA, Ogunledun A, Alli AO, Webber MA.

Int J Antimicrob Agents. 2011 Jan;37(1):62-6. doi: 10.1016/j.ijantimicag.2010.08.019. Epub 2010 Nov 11.

PMID:
21074376
41.

Prevalence of decreased susceptibility to triclosan in Salmonella enterica isolates from animals and humans and association with multiple drug resistance.

Copitch JL, Whitehead RN, Webber MA.

Int J Antimicrob Agents. 2010 Sep;36(3):247-51. doi: 10.1016/j.ijantimicag.2010.04.012. Epub 2010 Jun 11.

PMID:
20541914
42.

Measuring the activity of active efflux in gram-negative bacteria.

Webber MA, Coldham NG.

Methods Mol Biol. 2010;642:173-80. doi: 10.1007/978-1-60327-279-7_13.

PMID:
20401594
43.

Psychoneuroimmunological outcomes and quality of life.

Webber MA.

Transfus Apher Sci. 2010 Apr;42(2):157-61. doi: 10.1016/j.transci.2010.01.014. Epub 2010 Feb 8.

PMID:
20117053
44.

Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042.

Chaudhuri RR, Sebaihia M, Hobman JL, Webber MA, Leyton DL, Goldberg MD, Cunningham AF, Scott-Tucker A, Ferguson PR, Thomas CM, Frankel G, Tang CM, Dudley EG, Roberts IS, Rasko DA, Pallen MJ, Parkhill J, Nataro JP, Thomson NR, Henderson IR.

PLoS One. 2010 Jan 20;5(1):e8801. doi: 10.1371/journal.pone.0008801.

45.

Exposure of Escherichia coli and Salmonella enterica serovar Typhimurium to triclosan induces a species-specific response, including drug detoxification.

Bailey AM, Constantinidou C, Ivens A, Garvey MI, Webber MA, Coldham N, Hobman JL, Wain J, Woodward MJ, Piddock LJ.

J Antimicrob Chemother. 2009 Nov;64(5):973-85. doi: 10.1093/jac/dkp320. Epub 2009 Sep 16.

PMID:
19759044
46.

Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance phenotype.

Gunell M, Webber MA, Kotilainen P, Lilly AJ, Caddick JM, Jalava J, Huovinen P, Siitonen A, Hakanen AJ, Piddock LJ.

Antimicrob Agents Chemother. 2009 Sep;53(9):3832-6. doi: 10.1128/AAC.00121-09. Epub 2009 Jul 13.

47.

The global consequence of disruption of the AcrAB-TolC efflux pump in Salmonella enterica includes reduced expression of SPI-1 and other attributes required to infect the host.

Webber MA, Bailey AM, Blair JM, Morgan E, Stevens MP, Hinton JC, Ivens A, Wain J, Piddock LJ.

J Bacteriol. 2009 Jul;191(13):4276-85. doi: 10.1128/JB.00363-09. Epub 2009 May 1.

48.

Reduced fluoroquinolone susceptibility in Salmonella enterica isolates from travelers, Finland.

Lindgren MM, Kotilainen P, Huovinen P, Hurme S, Lukinmaa S, Webber MA, Piddock LJ, Siitonen A, Hakanen AJ.

Emerg Infect Dis. 2009 May;15(5):809-12. doi: 10.3201/eid1505.080849.

49.

A schema-focused approach to group psychotherapy for outpatients with borderline personality disorder: a randomized controlled trial.

Farrell JM, Shaw IA, Webber MA.

J Behav Ther Exp Psychiatry. 2009 Jun;40(2):317-28. doi: 10.1016/j.jbtep.2009.01.002. Epub 2009 Jan 14. Erratum in: J Behav Ther Exp Psychiatry. 2018 Apr 18;:.

PMID:
19176222
50.

Better pharmacotherapy for schizophrenia: what does the future hold?

Webber MA, Marder SR.

Curr Psychiatry Rep. 2008 Aug;10(4):352-8. Review.

PMID:
18627675

Supplemental Content

Loading ...
Support Center